Pierre Fabre Medicament, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for The 2nd largest dermo-cosmetics laboratory in the world and the 2nd largest private French pharmaceutical group.
One of their notable products is VINFLUNINE DITARTRATE, with a corresponding US DMF Number 17357.
Remarkably, this DMF maintains an Active status since its submission on April 22, 2004, highlighting commitment to regulatory compliance.